In year 2007, United States was already approved Avastin as a first line lung cancer treatment for patients with advance non small cell lung cancer in combination with platinum based echemotherapy.
Avastin is indicated for the first-line treatment of unresectable, locally advanced, recurrent or metastatic non–squamous non–small cell lung cancer in combination with carboplatin and paclitaxel.
Based [...]



